Preview of a PREVIEW
ADCs are coming in melanoma and James is stunned into silence for 45s
16 Okt 1min
Ep 89: PREVIEW ESMO Annual Meeting: 2026 Madrid
James and Sapna discuss all the meanings of the word "pike" and preview the presentations they are looking forward to at the 2026 ESMO Annual Congress from the Melanoma and Skin Tumours track. Sapna w...
16 Okt 15min
Ep 88: Negative Adjuvant Doublet Studies (CM915, KV010, RELA098)
Melanoma Matters: Why Adjuvant Doublet Immunotherapy Fell ShortHobbies - James wishes he was surfing more This episode breaks down three negative adjuvant melanoma trials testing combination immunothe...
1 Sep 22min
Ep 86: Teaser Tudriqev (RP1) FDA Approval
James asks the big question
25 Aug 10s
Ep 87: INTerpath-001 Press Release - August 2026
In this episode, Sapna and James discuss the INTerpath-001 press release describing primary endpoint (RFS) and key secondary endpoint (DMFS) findings from the randomized phase 3 study of individualize...
25 Aug 12min
Ep 86: Tudriqev (RP1) FDA Approval
In this episode, James and Sapna debate how to pronounce the newest FDA approved treatment for melanoma: T-U-D-R-I-Q-E-VThey discuss the FDA Cell and Gene Therapy Advisory Committee's review of the si...
25 Aug 52min
Ep 85: Surgical considerations for TIL
In this episode, Sapna and James talk tv shows - The Gambler and His Cowboys, Brassic... They discuss the paper from NKI on surgical considerations for TIL harvest published in BJS in 2025. Topics of ...
28 Juli 29min
